Toxicity grades 3 to 5 of adverse events until day 360 after HCT
| Toxicity . | Grades 3-5 . | |
|---|---|---|
| n . | % . | |
| Infections and infestations | 21 | 27.27 |
| Gastrointestinal disorders | 18 | 23.38 |
| Blood and lymphatic system disorders | 14 | 18.18 |
| General disorders | 2 | 2.60 |
| Respiratory, thoracic, and mediastinal disorders | 8 | 10.39 |
| Investigations | 6 | 7.79 |
| Vascular disorders | 4 | 5.19 |
| Metabolism and nutrition disorders | 2 | 2.60 |
| Eye disorders | 1 | 1.30 |
| Cardiac disorders | 3 | 3.90 |
| Musculoskeletal and connective tissue disorders | 1 | 1.30 |
| Renal and urinary disorders | 1 | 1.30 |
| Hepatobiliary disorders | 1 | 1.30 |
| Nervous system disorders | 1 | 1.30 |
| Psychiatric disorders | 1 | 1.30 |
| Toxicity . | Grades 3-5 . | |
|---|---|---|
| n . | % . | |
| Infections and infestations | 21 | 27.27 |
| Gastrointestinal disorders | 18 | 23.38 |
| Blood and lymphatic system disorders | 14 | 18.18 |
| General disorders | 2 | 2.60 |
| Respiratory, thoracic, and mediastinal disorders | 8 | 10.39 |
| Investigations | 6 | 7.79 |
| Vascular disorders | 4 | 5.19 |
| Metabolism and nutrition disorders | 2 | 2.60 |
| Eye disorders | 1 | 1.30 |
| Cardiac disorders | 3 | 3.90 |
| Musculoskeletal and connective tissue disorders | 1 | 1.30 |
| Renal and urinary disorders | 1 | 1.30 |
| Hepatobiliary disorders | 1 | 1.30 |
| Nervous system disorders | 1 | 1.30 |
| Psychiatric disorders | 1 | 1.30 |
Adverse events graded according to the Common Terminology Criteria Adverse Events (version 4.03: 14 June 2010).